


On one side is the collective withdrawal of lending and collateral-type vaults, while on the other side is the counter-trend growth of RWA and curation vaults. On-chain vaults are no longer a single market, but rather eight increasingly differentiated tracks. This ten-thousand-word research report t...
Why do businesses still need stablecoins? What problems do stablecoins actually solve?
Key Takeaways Visa is set to integrate support for four new stablecoins on four distinct blockchains, enhancing its…
Key Takeaways Visa is set to integrate support for four new stablecoins on four distinct blockchains, enhancing its…
Blockchain records reveal that no tokens have been distributed to any buyers in this hybrid gambling, memecoin, and…
Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.